Minerva gastroenterology最新文献_第6页

Probiotics plus vitamin D in irritable bowel syndrome: a prospective multicentric non-interventional study. 益生菌加维生素 D 治疗肠易激综合征：一项前瞻性多中心非干预研究。

IF 1.9

Minerva gastroenterology Pub Date : 2024-09-01 Epub Date: 2024-03-06 DOI: 10.23736/S2724-5985.24.03581-2

Pauline Jouët, Claude Altman, Stanislas Bruley DES Varannes, Christine Juhel, Franck Henri

{"title":"Probiotics plus vitamin D in irritable bowel syndrome: a prospective multicentric non-interventional study.","authors":"Pauline Jouët, Claude Altman, Stanislas Bruley DES Varannes, Christine Juhel, Franck Henri","doi":"10.23736/S2724-5985.24.03581-2","DOIUrl":"10.23736/S2724-5985.24.03581-2","url":null,"abstract":"Background: Patients with irritable bowel syndrome (IBS) experience recurrent symptoms and anxiety disorders that significantly impact their quality of life (QoL). The aim of the study was to assess in daily practice the benefit of the combination of three probiotic strains (Lactobacillus plantarum CETC 7484 and CETC 7485; Pediococcus acidilactici CECT 7483) plus vitamin D in patients with diarrhea-predominant IBS (IBS-D) or IBS with mixed bowel movements (IBS-M).Methods: This was a prospective, multicenter, non-interventional study in adult patients with IBS-D or IBS-M (Rome IV criteria) followed by private-practice gastroenterologists. Patients received daily one sachet of a combination of probiotics (3×109 CFU) and vitamin D (10 μg) for 42 days. The primary endpoint was the responder rate at D42 (≥50% and/or ≥100-point decrease of IBS-Severity Scoring System; IBS-SSS). Gut-related anxiety was measured with the Visceral Sensitivity Index (VSI).Results: The full analysis set population included 246 patients (mean age, 51.2±15.4 years; women, 73.2%; IBS-D, 56.1%; IBS-M, 43.9%). At D42, among the 89 patients with evaluable data, the responder rate was 62.9% with a mean decrease of IBS-SSS of 146.6±125.9 (P<0.0001). Changes of IBS-SSS were significantly correlated with changes of IBS-QoL (r=-0.78; P<0.0001), HAD-anxiety (r=0.46; P<0.0001), HAD-depression (r=0.61; P<0.001) and VSI (r=0.74; P<0.0001).Conclusions: These real-life results are in line with a previous randomized clinical trial demonstrating the benefits of this combination in IBS-D and IBS-M. Symptom relief was associated with improvement of IBS-QoL, anxiety, depression and specifically gut-related anxiety.","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":"332-341"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140041210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Application analysis of enteral immune nutritional support in postoperative radiotherapy and chemotherapy patients with colorectal cancer. 肠内免疫营养支持在癌症术后放化疗中的应用分析。

IF 1.9

Minerva gastroenterology Pub Date : 2024-09-01 Epub Date: 2023-10-27 DOI: 10.23736/S2724-5985.23.03526-X

Zhongpeng Zhu, Yongsheng Li

引用次数: 0

Diagnostic accuracy of antiendomysial antibodies biopsy test for celiac disease in clinical practice. 抗endomysial抗体活组织检查在临床实践中对乳糜泻的诊断准确性。

IF 1.9

Minerva gastroenterology Pub Date : 2024-09-01 Epub Date: 2023-10-05 DOI: 10.23736/S2724-5985.23.03396-X

Elisa Benelli, Giulia Zavarise, Paolo M Pavanello, Federica Mario, Giuseppina Barberio, Marco Gasparella, Francesca Galuppini, Ivana Cataldo, Maria Guido, Anna C Frigo, Stefano Martelossi

{"title":"Diagnostic accuracy of antiendomysial antibodies biopsy test for celiac disease in clinical practice.","authors":"Elisa Benelli, Giulia Zavarise, Paolo M Pavanello, Federica Mario, Giuseppina Barberio, Marco Gasparella, Francesca Galuppini, Ivana Cataldo, Maria Guido, Anna C Frigo, Stefano Martelossi","doi":"10.23736/S2724-5985.23.03396-X","DOIUrl":"10.23736/S2724-5985.23.03396-X","url":null,"abstract":"Background: The diagnosis of celiac disease (CD) is still challenging and tests that show an activation of the immune system against gluten are required. IgA antiendomysial antibodies detection in the supernatant of intestinal biopsies by immunofluorescence technique (AEA-biopsy) is a promising diagnostic tool. The aim of the present study was to evaluate the diagnostic accuracy of AEA-biopsy in a pediatric population with suspected CD.Methods: All children who underwent upper gastrointestinal endoscopy at the Unit of Pediatrics of Treviso Hospital were enrolled and divided into 4 groups: classical CD, CD excluded, potential CD and control group. For each patient, serum autoantibodies and histological evaluation were determined. Two additional biopsy samples were taken to test for presence of AEA.Results: A total of 92 patients were enrolled. All the classical CD cases (38) had a positive AEA-biopsy. In the CD excluded group (10 in total) AEA-biopsy was negative in all patients except 1. Among potential CD patients (which were 14), AEA-biopsy was negative in 4. In the control group (30 patients) AEA-biopsy was negative in all patients except 1. The sensitivity and specificity of AEA-biopsy were 100% and 96% respectively.Conclusions: AEA-biopsy has an excellent diagnostic accuracy in a routine clinical setting.","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":"291-298"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41159036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Analysis of the effect of PDCA nursing management on patient prevention complications and satisfaction after laser surgery in plastic and aesthetic clinics. PDCA护理管理对整形美容门诊激光手术患者预防并发症及满意度的影响分析。

IF 1.9

Minerva gastroenterology Pub Date : 2024-09-01 Epub Date: 2023-10-02 DOI: 10.23736/S2724-5985.23.03443-5

Chunyan Huang, Suping Lin, Shuhong Ge, Jingjing Xu

引用次数: 0

The effect and clinical application value of intestinal preparation self-assessment form on colonoscopy. 肠道准备自我评估表对结肠镜检查的影响及临床应用价值。

IF 1.9

Minerva gastroenterology Pub Date : 2024-07-02 DOI: 10.23736/S2724-5985.24.03697-0

Yingshuang Huang, Xiaoyan Yao, Jiayan Shen, Yining Gao, Guoping He, Shengpeng Geng

引用次数: 0

Markedly raised CA 19-9 levels in an asymptomatic patient: the role of Helicobacter pylori infection. 无症状患者体内 CA 19-9 水平明显升高：幽门螺杆菌感染的作用。

Minerva gastroenterology Pub Date : 2024-06-05 DOI: 10.23736/S2724-5985.24.03704-5

Angelo D'Agruma, Leonardo D'Agruma, Pamela Piscitelli, Paola Parente, Paolo Graziano, Gianluigi Vendemiale, Marco Castori, Giovanni B Gasbarrini, Salvatore DE Cosmo, Antonio Mirijello

引用次数: 0

Probiotic mixture in patients after Helicobacter pylori eradication: a real-life experience. 幽门螺旋杆菌根除后患者的益生菌混合物：现实生活中的经验。

IF 1.9

Minerva gastroenterology Pub Date : 2024-06-01 Epub Date: 2024-03-26 DOI: 10.23736/S2724-5985.24.03634-9

Salvatore E Aragona, Carlo Fabbri, Giovanni Cammarota, Giorgio Ciprandi

{"title":"Probiotic mixture in patients after Helicobacter pylori eradication: a real-life experience.","authors":"Salvatore E Aragona, Carlo Fabbri, Giovanni Cammarota, Giorgio Ciprandi","doi":"10.23736/S2724-5985.24.03634-9","DOIUrl":"10.23736/S2724-5985.24.03634-9","url":null,"abstract":"Background: Eradication for Helicobacter pylori usually induces digestive dysbiosis that, in turn, elicits symptoms. Consequently, probiotic supplementation may counterbalance the disturbed microbiota after this procedure. So, probiotics may restore microbiota homeostasis quickly relieve complaints.Methods: The current study evaluated the efficacy and safety of Abivisor®, a food supplement containing Lacticaseibacillus rhamnosus LR06 (3 billion living cells), Lactiplantibacillus pentosus LPS01(100 million living cells), Lactiplantibacillus plantarum LP01 (1 billion living cells), and N-acetyl cysteine (60 mg). Patients were randomized into two groups (2:1). Group A took one stick/daily for 60 days after eradication. Group B was considered as control. Patients were evaluated at baseline (T0) and after 15 (T1), 30 (T2), and 60 (T3) days. The severity of digestive symptoms was measured by patients using a Visual Analog Scale. The percentage of patients with each symptom was also evaluated.Results: Abivisor® has significantly and progressively diminished intestinal symptoms' presence and severity at T1, T2, and even more at T3. Accordingly, the percentage of symptomatic patients diminished more rapidly and significantly in group A than in B. All patients well tolerated the food supplement.Conclusions: The present study suggests that Abivisor® may be an effective and safe therapeutic option for managing patients undergoing H. pylori eradication.","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":"197-207"},"PeriodicalIF":1.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Can a combination of probiotics and nutraceuticals help preventing the abemaciclib-related diarrhea in breast cancer patients? 益生菌和营养保健品的组合能帮助乳腺癌患者预防与阿贝昔单抗相关的腹泻吗？

IF 1.9

Minerva gastroenterology Pub Date : 2024-06-01 Epub Date: 2024-03-14 DOI: 10.23736/S2724-5985.24.03647-7

Umberto Pacetti, Francesco DI Pierro, Massimiliano Cazzaniga, Ilaria Cavecchia, Mariarosaria Matera, Alexander Bertuccioli, Nicola Zerbinati, Luigina Guasti, Simonetta C Stani

引用次数: 0

Probiotics for managing patients after bowel preparation for colonoscopy: an interventional, double-arm, open, randomized, multi-center, and national study (COLONSTUDY). 在结肠镜检查肠道准备后使用益生菌管理患者：一项干预性、双臂、开放、随机、多中心和全国性研究（COLONSTUDY）。

IF 1.9

Minerva gastroenterology Pub Date : 2024-06-01 DOI: 10.23736/S2724-5985.24.03630-1

Salvatore E Aragona, Cristiano Spada, Luca DE Luca, Elena Aragona, Giorgio Ciprandi

{"title":"Probiotics for managing patients after bowel preparation for colonoscopy: an interventional, double-arm, open, randomized, multi-center, and national study (COLONSTUDY).","authors":"Salvatore E Aragona, Cristiano Spada, Luca DE Luca, Elena Aragona, Giorgio Ciprandi","doi":"10.23736/S2724-5985.24.03630-1","DOIUrl":"10.23736/S2724-5985.24.03630-1","url":null,"abstract":"Background: Bowel preparation (BP) for colonoscopy induces significant changes in gut microbiota, causing dysbiosis that, in turn, elicits intestinal symptoms. Consequently, probiotics may counterbalance the disturbed microbiota after BP. So, probiotics may restore microbiota homeostasis.Methods: The current study evaluated the efficacy and safety of Abincol®, an oral nutraceutical containing a probiotic mixture with Lactobacillus plantarum LP01 (1 billion living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 millions living cells), and Lactobacillus delbrueckii LDD01 (200 millions living cells), Patients were randomized in two groups (2:1). Group A took one stick/daily for four weeks after colonoscopy. Group B was considered as control. Patients were evaluated at baseline (T0) and after one (T1), two (T2), and four (T3) weeks. The severity of symptoms was measured by patients using a Visual Analog Scale.Results: Abincol® significantly diminished the presence and the severity of intestinal symptoms at T2 and even more at T3. All patients well tolerated the probiotic mixture.Conclusions: The present study suggests that Abincol® may be considered an effective and safe therapeutic option in managing patients undergoing BP. The course should last one month.","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":"70 2","pages":"187-196"},"PeriodicalIF":1.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141181759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Gastrointestinal symptoms, dietary regimen and anxiety levels during the COVID-19 pandemic among medical students: results from a web-based survey. 医学生在 COVID-19 大流行期间的胃肠道症状、饮食疗法和焦虑水平：一项网络调查的结果。

IF 1.9

Minerva gastroenterology Pub Date : 2024-06-01 Epub Date: 2024-02-06 DOI: 10.23736/S2724-5985.24.03648-9

Ludovico Abenavoli, Giuseppe G M Scarlata, Roman Myazin, Dmitry Emelyanov

引用次数: 0